Capparis spinosa L. aqueous extract evokes antidiabetic effect in streptozotocin-induced diabetic mice

Abstract

<br /><strong>Objective</strong>: As the aqueous extract of <em>Capparis spinosa</em> (CS) possess antidiabetic effect, he present study aims to reveal the possible mechanism of action of CS in diabetic mice.<br /><br /><strong>Materials and Methods</strong>: Both single and repeated oral administrations of aqueous extract of CS were performed in multi-low dose streptozotocin-induced (MLDS) diabetic mice. Euglycemic hyperinsulinemic clamp was used in association with the endogenous glucose production (perfusion rate of 3-³H glucose) to evaluate the effect of CS aqueous extract on insulin sensitivity.<br /><br /><strong>Results</strong>: Our study showed that aqueous extract of CS possess a potent hypoglycaemic activity in MLDS diabetic mice. Furthermore, the analysis perfusion of 3-³H glucose demonstrated the parallel decrease of basal endogenous glucose production (EGP) with the hypoglycaemic activity. EGP was lower in CS-Treated group when compared to the control group (p<0.001). The euglycemic hyperinsulinemic clamp technique demonstrated that CS treatment improves insulin sensitivity in peripheral tissues.<br /><br /><strong>Conclusion</strong>: We conclude that the antihyperglycemic effet CS is probably due to the inhibition of basal endogenous glucose production and the improvement of insulin sensitivity in MLDS diabetic mice.